| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|
| Service revenue | 20,942 | NaN | NaN | |
| Gross profit (loss) | 20,942 | NaN | NaN | |
| General and administrative | 1,421,255 | 1,766,210 | 2,410,516 | |
| Research and development | 15,946 | 45,872 | 24,407 | |
| Goodwill impairment | 0 | NaN | 0 | |
| Long-lived asset impairment | NaN | NaN | 831,915 | |
| Depreciation and amortization | 11,001 | 11,332 | 41,522 | |
| Total operating expenses | 1,448,202 | 1,823,414 | 3,308,360 | |
| Loss from operations | -1,477,260 | -1,823,414 | -3,308,360 | |
| Change in fair value of contingent consideration | 70,000 | 140,000 | 370,000 | |
| Change in fair value of equity securities | NaN | NaN | 156,849 | |
| Gain on bankruptcy of subsidiary | NaN | NaN | 12,019,227 | |
| Loss on extinguishment of debt | -1,086,116 | NaN | -6,329,592 | |
| Interest expense | 108,052 | 121,508 | 122,400 | |
| Interest and other income | NaN | 5,518 | NaN | |
| Interest and other income (expense) | -19,966 | NaN | 33,297 | |
| Total other income (expense) | -1,144,134 | 24,010 | 6,127,381 | |
| Net income (loss) | -2,571,394 | -1,799,404 | 2,819,021 | |
| Basic EPS | -0.1 | -0.08 | 0.13 | |
| Diluted EPS | -0.1 | -0.08 | 0.13 | |
| Basic Average Shares | 24,994,200 | 23,482,714 | 22,520,245 | |
| Diluted Average Shares | 24,994,200 | 23,482,714 | 22,520,245 | |
Lunai Bioworks Inc. (LNAI)
Lunai Bioworks Inc. (LNAI)